← Product Code [GSZ](/submissions/MI/subpart-d%E2%80%94serological-reagents/GSZ) · K760881

# FEBRILE ANTIGEN CONTROL SERA (K760881)

_Bd Becton Dickinson Vacutainer Systems Preanalytic · GSZ · Nov 9, 1976 · Microbiology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/IM/subpart-d%E2%80%94serological-reagents/GSZ/K760881

## Device Facts

- **Applicant:** Bd Becton Dickinson Vacutainer Systems Preanalytic
- **Product Code:** [GSZ](/submissions/MI/subpart-d%E2%80%94serological-reagents/GSZ.md)
- **Decision Date:** Nov 9, 1976
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 866.3410
- **Device Class:** Class 1
- **Review Panel:** Microbiology

## Regulatory Identification

Proteus spp. (Weil-Felix) serological reagents are devices that consist of antigens and antisera, including antisera conjugated with a fluorescent dye (immunofluorescent reagents), derived from the bacterium Proteus vulgaris used in agglutination tests (a specific type of antigen-antibody reaction) for the detection of antibodies to rickettsia (virus-like bacteria) in serum. Test results aid in the diagnosis of diseases caused by bacteria belonging to the genus Rickettsiae and provide epidemiological information on these diseases. Rickettsia are generally transmitted by arthropods (e.g., ticks and mosquitoes) and produce infections in humans characterized by rash and fever (e.g., typhus fever, spotted fever, Q fever, and trench fever).

---

**Source:** [https://fda.innolitics.com/submissions/IM/subpart-d%E2%80%94serological-reagents/GSZ/K760881](https://fda.innolitics.com/submissions/IM/subpart-d%E2%80%94serological-reagents/GSZ/K760881)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com